ArticleAntimicrobial agents and chemotherapy2000

Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.

A M Lenaerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.